Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected Patients

ClinicalTrials.gov ID: NCT00000643

Public ClinicalTrials.gov record NCT00000643. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 11:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the effectiveness of pyrimethamine (given with leucovorin calcium versus placebo (an inactive substance) for the primary prophylaxis (prevention) of cerebral toxoplasmosis in HIV-infected patients. Cerebral toxoplasmosis is one of the most frequently encountered opportunistic infections in the course of AIDS. The mortality (death) rate is estimated to be greater than 50 percent. Pyrimethamine is a drug that appears promising for the primary prevention of cerebral toxoplasmosis in HIV-infected patients.

Study identification

NCT ID
NCT00000643
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
150 participants

Conditions and interventions

Eligibility (public fields only)

Age range
13 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Apr 30, 1994
Last update posted
Nov 1, 2021

Ends 1994

United States locations

U.S. sites
24
U.S. states
14
U.S. cities
19
Facility City State ZIP Site status
Stanford CRS Palo Alto California 94304
Harbor-UCLA Med. Ctr. CRS Torrance California 90502
Univ. of Miami AIDS CRS Miami Florida 33136
Northwestern University CRS Chicago Illinois 60611
Rush Univ. Med. Ctr. ACTG CRS Chicago Illinois 60611
Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis Indiana 46202
Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU New Orleans Louisiana
Johns Hopkins Adult AIDS CRS Baltimore Maryland 21287
Bmc Actg Crs Boston Massachusetts 02118
University of Minnesota, ACTU Minneapolis Minnesota 55455
St. Louis ConnectCare, Infectious Diseases Clinic St Louis Missouri
Washington U CRS St Louis Missouri
NJ Med. School CRS Newark New Jersey 07103
SUNY - Buffalo, Erie County Medical Ctr. Buffalo New York 14215
Beth Israel Med. Ctr. (Mt. Sinai) New York New York 10003
NY Univ. HIV/AIDS CRS New York New York 10016
Cornell University A2201 New York New York 10021
Memorial Sloan-Kettering Cancer Ctr. New York New York 10021
Univ. of Rochester ACTG CRS Rochester New York 14642
Unc Aids Crs Chapel Hill North Carolina 27599
Duke Univ. Med. Ctr. Adult CRS Durham North Carolina 27710
Univ. of Cincinnati CRS Cincinnati Ohio 45267
Case CRS Cleveland Ohio 44106
Pitt CRS Pittsburgh Pennsylvania 15213

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00000643, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 1, 2021 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00000643 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →